+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
Raynaud's Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Raynaud's Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pulmonary Embolism - Pipeline Insight, 2025 - Product Thumbnail Image

Pulmonary Embolism - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pruritus - Pipeline Insight, 2025 - Product Thumbnail Image

Pruritus - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Narcolepsy - Pipeline Insight, 2025 - Product Thumbnail Image

Narcolepsy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 75 Pages
  • Global
From
Ischemic Stroke - Pipeline Insight, 2025 - Product Thumbnail Image

Ischemic Stroke - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Ischemic Cardiomyopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Ischemic Cardiomyopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ischemia Reperfusion Injury - Pipeline Insight, 2025 - Product Thumbnail Image

Ischemia Reperfusion Injury - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Interstitial Cystitis - Pipeline Insight, 2025 - Product Thumbnail Image

Interstitial Cystitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Intermittent Claudication - Pipeline Insight, 2025 - Product Thumbnail Image

Intermittent Claudication - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dilated Cardiomyopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Dilated Cardiomyopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Glucokinase Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Glucokinase Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Blood Coagulation Factor Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Blood Coagulation Factor Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Vaginitis - Pipeline Insight, 2025 - Product Thumbnail Image

Vaginitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Partial Seizure - Pipeline Insight, 2025 - Product Thumbnail Image

Partial Seizure - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pancreatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Otitis Media- Pipeline Insight, 2025 - Product Thumbnail Image

Otitis Media- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Male Infertility - Pipeline Insight, 2025 - Product Thumbnail Image

Male Infertility - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Male Hypogonadism - Pipeline Insight, 2025 - Product Thumbnail Image

Male Hypogonadism - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hyperalgesia - Pipeline Insight, 2025 - Product Thumbnail Image

Hyperalgesia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more